Cited by 204Liver physiology and pathologyLiver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets

Ezhilarasan, Devaraj, Sokal, Etienne, Najimi, Mustapha·2018·Hepatobiliary & Pancreatic Diseases International

Abstract

Hepatic fibrosis is a pathological lesion, characterized by the progressive accumulation of extracellular matrix (ECM) in the perisinusoidal space and it is a major problem in chronic liver diseases. Phenotypic activation of hepatic stellate cells (HSC) plays a central role in the progression of hepatic fibrosis. Retardation of proliferation and clearance of activated HSCs from the injured liver is an appropriate therapeutic strategy for the resolution and treatment of hepatic fibrosis. Clearance of activated HSCs from the injured liver by autophagy inhibitors, proapoptotic agents and senescence inducers with the high affinity toward the activated HSCs may be the novel therapeutic strategy for the treatment of hepatic fibrosis in the near future.

Integrity signals

Registry

Crossref · 10.1016/j.hbpd.2018.04.003

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Activated hepatic stellate cells are the major functional population during liver fibrogenesis.

    “Activated hepatic stellate cells are the major functional population during liver fibrogenesis.154”

Cites

Flagged first, then by citations

3 of the 71 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ezhilarasan, D., Sokal, E., & Najimi, M.
Affiliations
  • Saveetha University (IN)
  • UCLouvain (BE)
Corresponding author
Ezhilarasan, Devaraj
Venue
Hepatobiliary & Pancreatic Diseases International
Publisher
Elsevier BV
Published
2018-06
Volume
17
Issue
3
Pages
192-197
ISSN
  • 2352-9377 (ISSN-L)
  • 1499-3872
OpenAlex
W2802633545
Cited by
204
References
71
Citations by year
2026: 6 · 2025: 20 · 2024: 16 · 2023: 27 · 2022: 28 · 2021: 64 · 2020: 32 · 2019: 10 · 2012: 1
FWCI
16.60
Type
journal article
Language
en
Open access
closed
Locations
  • Hepatobiliary & pancreatic diseases international (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
Keywords
liver fibrosis, hepatic stellate cells, hepatic stellate cell activation, extracellular matrix accumulation, chronic liver disease, autophagy inhibitors, cellular senescence, antifibrotic therapy
MeSH terms
Animals, Autophagy, Extracellular Matrix, Humans, Liver, Liver Cirrhosis, Phenotype, Signal Transduction, Cellular Senescence, Apoptosis, Cell Proliferation, Hepatic Stellate Cells, Myofibroblasts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review